Titre : 5-Méthyl-cytosine

5-Méthyl-cytosine : Questions médicales fréquentes

Termes MeSH sélectionnés :

Young Adult
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "5-Méthyl-cytosine : Questions médicales les plus fréquentes", "headline": "5-Méthyl-cytosine : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les 5-Méthyl-cytosine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-31", "dateModified": "2025-03-26", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "5-Méthyl-cytosine" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Cytosine", "url": "https://questionsmedicales.fr/mesh/D003596", "about": { "@type": "MedicalCondition", "name": "Cytosine", "code": { "@type": "MedicalCode", "code": "D003596", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.383.742.698.421" } } }, "about": { "@type": "MedicalCondition", "name": "5-Méthyl-cytosine", "alternateName": "5-Methylcytosine", "code": { "@type": "MedicalCode", "code": "D044503", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Yun-Gui Yang", "url": "https://questionsmedicales.fr/author/Yun-Gui%20Yang", "affiliation": { "@type": "Organization", "name": "CAS Key Laboratory of Genomic and Precision Medicine, Collaborative Innovation Center of Genetics and Development, College of Future Technology, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China; Sino-Danish College, University of Chinese Academy of Sciences, Beijing 101408, China; Institute of Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing 100101, China. Electronic address: ygyang@big.ac.cn." } }, { "@type": "Person", "name": "Ying Yang", "url": "https://questionsmedicales.fr/author/Ying%20Yang", "affiliation": { "@type": "Organization", "name": "CAS Key Laboratory of Genomic and Precision Medicine, College of Futuer Technology, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China." } }, { "@type": "Person", "name": "Qing Dai", "url": "https://questionsmedicales.fr/author/Qing%20Dai", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, The University of Chicago, Chicago, IL 60637." } }, { "@type": "Person", "name": "Chuan He", "url": "https://questionsmedicales.fr/author/Chuan%20He", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, The University of Chicago, Chicago, IL 60637." } }, { "@type": "Person", "name": "Bao-Fa Sun", "url": "https://questionsmedicales.fr/author/Bao-Fa%20Sun", "affiliation": { "@type": "Organization", "name": "CAS Key Laboratory of Genomic and Precision Medicine, College of Futuer Technology, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Cardiometabolic risk in young adults with Down syndrome.", "datePublished": "2023-03-31", "url": "https://questionsmedicales.fr/article/37000612", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/ajmg.a.63197" } }, { "@type": "ScholarlyArticle", "name": "Grading bias and young adult mental health.", "datePublished": "2022-12-07", "url": "https://questionsmedicales.fr/article/36479780", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/hec.4639" } }, { "@type": "ScholarlyArticle", "name": "Language Impairment in Autistic Adolescents and Young Adults.", "datePublished": "2022-09-06", "url": "https://questionsmedicales.fr/article/36067514", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1044/2022_JSLHR-21-00517" } }, { "@type": "ScholarlyArticle", "name": "The extremely preterm young adult - State of the art.", "datePublished": "2022-06-02", "url": "https://questionsmedicales.fr/article/35710530", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.siny.2022.101365" } }, { "@type": "ScholarlyArticle", "name": "Multiple Myeloma in a Young Adult: A Case Report.", "datePublished": "2023-02-10", "url": "https://questionsmedicales.fr/article/36763805", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2106/JBJS.CC.22.00537" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Composés hétéromonocycliques", "item": "https://questionsmedicales.fr/mesh/D006573" }, { "@type": "ListItem", "position": 4, "name": "Pyrimidines", "item": "https://questionsmedicales.fr/mesh/D011743" }, { "@type": "ListItem", "position": 5, "name": "Pyrimidinones", "item": "https://questionsmedicales.fr/mesh/D011744" }, { "@type": "ListItem", "position": 6, "name": "Cytosine", "item": "https://questionsmedicales.fr/mesh/D003596" }, { "@type": "ListItem", "position": 7, "name": "5-Méthyl-cytosine", "item": "https://questionsmedicales.fr/mesh/D044503" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : 5-Méthyl-cytosine - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur 5-Méthyl-cytosine", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-19", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur 5-Méthyl-cytosine", "description": "Comment détecte-t-on la 5-méthylcytosine ?\nQuels tests sont utilisés pour évaluer la méthylation ?\nLa 5-méthylcytosine est-elle mesurable dans le sang ?\nQuels biomarqueurs sont associés à la 5-méthylcytosine ?\nLa 5-méthylcytosine est-elle liée à des maladies ?", "url": "https://questionsmedicales.fr/mesh/D044503?mesh_terms=Young+Adult&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur 5-Méthyl-cytosine", "description": "Quels symptômes sont liés à la méthylation anormale ?\nLa 5-méthylcytosine affecte-t-elle le comportement ?\nY a-t-il des signes cliniques de dysfonctionnement ?\nLa 5-méthylcytosine est-elle liée à des symptômes neurologiques ?\nPeut-on observer des symptômes cutanés ?", "url": "https://questionsmedicales.fr/mesh/D044503?mesh_terms=Young+Adult&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur 5-Méthyl-cytosine", "description": "Comment prévenir les anomalies de méthylation ?\nLe stress influence-t-il la méthylation ?\nLes suppléments nutritionnels aident-ils ?\nL'exercice physique a-t-il un impact ?\nLes habitudes de sommeil affectent-elles la méthylation ?", "url": "https://questionsmedicales.fr/mesh/D044503?mesh_terms=Young+Adult&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur 5-Méthyl-cytosine", "description": "Quels traitements ciblent la méthylation ?\nLa thérapie génique peut-elle corriger la méthylation ?\nY a-t-il des traitements préventifs ?\nLes médicaments peuvent-ils influencer la méthylation ?\nComment la recherche avance-t-elle sur ce sujet ?", "url": "https://questionsmedicales.fr/mesh/D044503?mesh_terms=Young+Adult&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur 5-Méthyl-cytosine", "description": "Quelles complications sont liées à la méthylation anormale ?\nLa 5-méthylcytosine est-elle liée à des troubles mentaux ?\nY a-t-il des risques de maladies cardiovasculaires ?\nLes complications peuvent-elles être réversibles ?\nLa 5-méthylcytosine affecte-t-elle la fertilité ?", "url": "https://questionsmedicales.fr/mesh/D044503?mesh_terms=Young+Adult&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur 5-Méthyl-cytosine", "description": "Quels facteurs augmentent le risque de méthylation anormale ?\nLe tabagisme influence-t-il la méthylation ?\nL'environnement joue-t-il un rôle ?\nLes antécédents familiaux influencent-ils le risque ?\nLe mode de vie a-t-il un impact sur la méthylation ?", "url": "https://questionsmedicales.fr/mesh/D044503?mesh_terms=Young+Adult&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment détecte-t-on la 5-méthylcytosine ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "La détection se fait par des techniques comme la bisulfite séquençage." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer la méthylation ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme le PCR en temps réel et le séquençage de nouvelle génération sont utilisés." } }, { "@type": "Question", "name": "La 5-méthylcytosine est-elle mesurable dans le sang ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des échantillons sanguins peuvent être analysés pour la méthylation de l'ADN." } }, { "@type": "Question", "name": "Quels biomarqueurs sont associés à la 5-méthylcytosine ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des biomarqueurs comme les gènes régulés par la méthylation peuvent être identifiés." } }, { "@type": "Question", "name": "La 5-méthylcytosine est-elle liée à des maladies ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est associée à des maladies comme le cancer et des troubles neurologiques." } }, { "@type": "Question", "name": "Quels symptômes sont liés à la méthylation anormale ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes peuvent inclure des troubles cognitifs et des anomalies de développement." } }, { "@type": "Question", "name": "La 5-méthylcytosine affecte-t-elle le comportement ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des modifications de la méthylation peuvent influencer le comportement et l'humeur." } }, { "@type": "Question", "name": "Y a-t-il des signes cliniques de dysfonctionnement ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des signes peuvent inclure des troubles métaboliques et des problèmes immunitaires." } }, { "@type": "Question", "name": "La 5-méthylcytosine est-elle liée à des symptômes neurologiques ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est impliquée dans des maladies neurodégénératives et des troubles psychiatriques." } }, { "@type": "Question", "name": "Peut-on observer des symptômes cutanés ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies cutanées peuvent survenir en raison de troubles liés à la méthylation." } }, { "@type": "Question", "name": "Comment prévenir les anomalies de méthylation ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et un mode de vie sain peuvent réduire les risques." } }, { "@type": "Question", "name": "Le stress influence-t-il la méthylation ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut affecter les niveaux de méthylation de l'ADN." } }, { "@type": "Question", "name": "Les suppléments nutritionnels aident-ils ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Certains suppléments, comme l'acide folique, peuvent soutenir une méthylation saine." } }, { "@type": "Question", "name": "L'exercice physique a-t-il un impact ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut influencer positivement la méthylation de l'ADN." } }, { "@type": "Question", "name": "Les habitudes de sommeil affectent-elles la méthylation ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Un sommeil de qualité est crucial pour maintenir une méthylation adéquate." } }, { "@type": "Question", "name": "Quels traitements ciblent la méthylation ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des agents déméthylants comme l'azacitidine sont utilisés pour traiter certains cancers." } }, { "@type": "Question", "name": "La thérapie génique peut-elle corriger la méthylation ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la thérapie génique vise à restaurer la méthylation normale dans certaines conditions." } }, { "@type": "Question", "name": "Y a-t-il des traitements préventifs ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des interventions diététiques et des modifications du mode de vie peuvent aider à prévenir des anomalies." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils influencer la méthylation ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments peuvent modifier les niveaux de méthylation de l'ADN." } }, { "@type": "Question", "name": "Comment la recherche avance-t-elle sur ce sujet ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des études cliniques explorent de nouvelles thérapies ciblant la méthylation pour diverses maladies." } }, { "@type": "Question", "name": "Quelles complications sont liées à la méthylation anormale ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent le développement de cancers et de maladies auto-immunes." } }, { "@type": "Question", "name": "La 5-méthylcytosine est-elle liée à des troubles mentaux ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies de méthylation peuvent contribuer à des troubles mentaux comme la dépression." } }, { "@type": "Question", "name": "Y a-t-il des risques de maladies cardiovasculaires ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des études suggèrent un lien entre la méthylation et les maladies cardiovasculaires." } }, { "@type": "Question", "name": "Les complications peuvent-elles être réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être atténuées par des traitements ciblés et des changements de mode de vie." } }, { "@type": "Question", "name": "La 5-méthylcytosine affecte-t-elle la fertilité ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des modifications de méthylation peuvent influencer la fertilité et le développement embryonnaire." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de méthylation anormale ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme l'âge, l'alimentation et l'exposition à des toxines peuvent augmenter le risque." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il la méthylation ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme est associé à des modifications de la méthylation de l'ADN." } }, { "@type": "Question", "name": "L'environnement joue-t-il un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des facteurs environnementaux comme la pollution peuvent affecter la méthylation." } }, { "@type": "Question", "name": "Les antécédents familiaux influencent-ils le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de maladies peuvent augmenter le risque de méthylation anormale." } }, { "@type": "Question", "name": "Le mode de vie a-t-il un impact sur la méthylation ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent affecter la méthylation." } } ] } ] }

Sources (10000 au total)

Language Impairment in Autistic Adolescents and Young Adults.

Little is known about the specific nature of language abilities of autistic adolescents and young adults with language impairment (LI), limiting our knowledge of developmental trajectories and ability... Thirteen autistic adolescents and young adults completed an assessment protocol of age-referenced language and nonverbal cognitive assessments. Assessment took place once per year for 3 years; the fir... All participants qualified for LI, with overall receptive and expressive language scores persistently in the LI range. Other outcomes were variable. Some participants had nonword repetition and vocabu... Our findings support the use of the current protocol, as implemented in person or online, to identify LI in autistic adolescents and young adults. This exploratory work is limited by a small sample an...

Multiple Myeloma in a Young Adult: A Case Report.

We present a 27-year-old man who presented with worsened back pain after a fall from a ladder. Unrelenting pain prompted the discovery through imaging and biopsy of a large pelvic plasmacytoma along w... The typical age at diagnosis for MM is 60 to 70 years. This case emphasizes the need to consider MM when diagnosing patients younger than 30 years, especially those with numerous bony lesions....

Cancer burden in adolescents and young adults in Europe.

Cancer epidemiology is unique in adolescents and young adults (AYAs; aged 15-39 years). The European Society for Medical Oncology/European Society for Paediatric Oncology (ESMO/SIOPE) AYA Working Grou... We used data available on the Global Cancer Observatory. We retrieved crude and age-standardised (World Standard Population) incidence and mortality rates. We reported about AYA cancer burden in Europ... Incidence and mortality varied widely between countries with the highest mortality observed in Eastern EU countries. Cancers of the female breast, thyroid and male testis were the most common cancers ... Our results highlight the future health care needs and requirements for AYA-specialised services to ensure a homogeneous treatment across different countries as well as the urgency for preventive init...

Coronary artery calcium testing in young adults.

To provide a summary of recent literature on coronary artery calcium testing (CAC) for risk stratification in young adults <45 years old.... One of every ten young adults in the general population, and one out of every three young adults with traditional atherosclerotic cardiovascular disease (ASCVD) risk factors, have CAC. While the defin... The identification of premature CAC is important because it suggests that calcific plaque can be detected with modern imaging earlier in the natural history than previously thought. Taken together, th...

Predicting timely transfer to adult care in a cohort of autistic adolescents and young adults.

The transition from pediatric to adult care is a challenge for autistic adolescents and young adults. Data on patient features associated with timely transfer between pediatric and adult health care a... We analyzed pediatric and adult electronic medical record data from a cohort of adolescents and young adults who established with a primary-care based program for autistic adolescents and young adults... Total outpatient encounters and total encounters in pediatric care showed good ability to predict timely transfer to adult health care in a population of autistic adolescents and young adults....

Localised Synovial Sarcoma in Adolescents and Young Adults Versus Adults - Is There a Difference in Outcome?

Synovial sarcomas are a rare subgroup of soft-tissue sarcoma arising in adolescents and young adults (AYA) and in adult patients. The objective of our analysis was to investigate the outcomes and pote... In total, 51 patients (25 AYA and 26 adult) were identified and evaluated in this retrospective single centre analysis. Baseline characteristics, treatment and outcome were assessed.... The predominant subtype in both groups was monophasic synovial sarcoma (17 AYA and 21 adult) and the most common site was the extremities (14 and 19 patients) with deep tumour location in both groups ... AYA and adult patients showed no significant difference in terms of overall survival. Male gender, tumour size >5 cm and progressive disease were prognostic markers for worse outcome, whereas tumour l...